A prospective study of patients with refractory angina: outcomes and the role of high-sensitivity troponin T

Imagem de Miniatura
Arquivos
art_POPPI_A_prospective_study_of_patients_with_refractory_angina_2017.PDF (958.99 KB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
Citação
CLINICAL CARDIOLOGY, v.40, n.1, p.11-17, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundThe predictors of cardiovascular events in patients with chronic refractory angina are limited. High-sensitivity cardiac troponin T (hs-cTnT) assays are biomarkers that may be used to determine the prognosis of patients with stable coronary artery disease. HypothesisHs-cTnT is a predictor of death and nonfatal myocardial infarction (MI) in patients with refractory angina. MethodsWe prospectively enrolled 117 consecutive patients in this study. A heart team ruled out myocardial revascularization feasibility after assessing recent coronary angiograms; evidence of myocardial ischemia served as an inclusion criterion. Optimal medical therapy was encouraged via outpatient visits every 6 months; plasma hs-cTnT levels were determined at baseline. The primary endpoint was the composite incidence of death and nonfatal MI. ResultsDuring a median follow-up period of 28.0 months (interquartile range, 18.0-47.5 months), an estimated 28.0-month cumulative event rate of 13.4% was determined via the Kaplan-Meier method. Univariate predictors of the composite endpoint were hs-cTnT levels and LV dysfunction. Following a multivariate analysis, only hs-cTnT was independently associated with the events in question, either as a continuous variable (hazard ratio per unit increase in the natural logarithm: 2.83, 95% confidence interval: 1.62-4.92, P < 0.001) or as a categorical variable (hazard ratio for concentrations above the 99th percentile: 5.14, 95% confidence interval: 2.05-12.91, P < 0.001). ConclusionsIn patients with chronic refractory angina, plasma concentration of hs-cTnT is the strongest predictor of death and nonfatal MI. Notably, none of the outcomes in question occurred in patients with baseline plasma levels <5.0 ng/L.
Palavras-chave
chronic refractory angina, high-sensitivity troponin, prognosis
URI
https://observatorio.fm.usp.br/handle/OPI/18771
Referências
  1. Allen KB, 1999, NEW ENGL J MED, V341, P1029, DOI 10.1056/NEJM199909303411403
  2. Andrassy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052081
  3. Andrell P, 2011, INT J CARDIOL, V147, P377, DOI 10.1016/j.ijcard.2009.09.538
  4. Apple FS, 2012, CLIN CHEM, V58, P930, DOI 10.1373/clinchem.2011.179176
  5. Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795
  6. Beatty AL, 2013, JAMA INTERN MED, V173, P763, DOI 10.1001/jamainternmed.2013.116
  7. Borekci A, 2015, PERFUSION-UK, V30, P457, DOI 10.1177/0267659114558287
  8. deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708
  9. Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013
  10. Henry TD, 2014, NAT REV CARDIOL, V11, P78, DOI 10.1038/nrcardio.2013.200
  11. Henry TD, 2013, EUR HEART J, V34, P2683, DOI 10.1093/eurheartj/eht165
  12. Khan AR, 2016, CIRC RES, V118, P984, DOI 10.1161/CIRCRESAHA.115.308056
  13. Koenig W, 2012, CLIN CHEM, V58, P1215, DOI 10.1373/clinchem.2012.183319
  14. Konishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060163
  15. Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201
  16. Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394
  17. Lawson WE, 2015, CLIN CARDIOL, V38, P344, DOI 10.1002/clc.22395
  18. Lenzen Mattie, 2006, Eur J Cardiovasc Nurs, V5, P115, DOI 10.1016/j.ejcnurse.2006.01.003
  19. Loh PH, 2008, CLIN CARDIOL, V31, P159, DOI 10.1002/clc.20117
  20. Mannheimer C, 2002, EUR HEART J, V23, P355, DOI 10.1053/euhj.2001.2706
  21. McGillion M, 2012, CAN J CARDIOL, V28, pS20, DOI 10.1016/j.cjca.2011.07.007
  22. Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5
  23. Mukherjee D, 2001, AM HEART J, V142, P72, DOI 10.1067/mhj.2001.115786
  24. Ndrepepa G, 2011, EUR J CLIN INVEST, V41, P1054, DOI 10.1111/j.1365-2362.2011.02500.x
  25. Ndrepepa G, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.018
  26. Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026
  27. Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299
  28. Poppi NT, 2017, CLIN CARDIOL, V40, P11, DOI 10.1002/clc.22599
  29. Povsic TJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001287
  30. Ruck A, 2008, SCAND CARDIOVASC J, V42, P291, DOI 10.1080/14017430802084997
  31. TenVaarwerk IAM, 1999, HEART, V82, P82
  32. Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001
  33. Verheye S, 2015, NEW ENGL J MED, V372, P519, DOI 10.1056/NEJMoa1402556
  34. Williams B, 2010, CATHETER CARDIO INTE, V75, P886, DOI 10.1002/ccd.22431

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/13
Artigos e Materiais de Revistas Científicas - ODS/03